Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
MGH collaboration to evaluate TRE-515 in ALS patients, advancing development of a first-in-class therapy targeting inflammation and nucleotide metabolism.
-
Sangamo Therapeutics reports recent business highlights and fourth quarter and full year 2025 financial results
-
The neuroprotective agents market in North America is growing at approximately 4.5% CAGR through 2030, with AI-driven approaches.
-
The global market for neuroprotective agents was valued at $41.2 billion in 2024 and is expected to reach $60.9 billion by the end of 2030.
-
Peer-reviewed publication validates the potential of Itay&Beyond's human CNS platform for advanced disease stratification, translational research, and R&D
-
MELBOURNE, Australia and SAN FRANCISCO, March 04, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to...
-
BEDFORD, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Spryte Medical, a pioneer in intravascular neuro imaging, today announced the successful enrollment of the first participants in the INSYTE trial...
-
Hot Springs Arkansas Neurologist Kara Way Opens New Way Neurology
-
Dublin, Feb. 26, 2026 (GLOBE NEWSWIRE) -- The "Immunoassay for Neurological Biomarkers Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ...
-
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE L'IDENTIFICATION D'UN BIOMARQUEUR PLASMATIQUE MARQUEUR DE L'ACTIVITÉ DU MASITINIB DANS LE TRAITEMENT DE LA SCLÉROSE LATÉRALE AMYOTROPHIQUE, ET CAPABLE...